New course on Ellipta devices in COPD and asthma

3d set of orange lungs
With just two weeks until the end of the CPD year, the Guild Academy has announced an online course to assist pharmacists in understanding the use of Ellipta devices in COPD and asthma. The 2014-15 Australian Health Survey estimated that 2.5 million Australians are affected by asthma and a further 600,000 are affected by COPD. 

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Three key pillars of good public health
Next 'We can’t afford not to' spend on public health